Edition:
United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

34.37CNY
21 May 2018
Change (% chg)

-- (--)
Prev Close
¥34.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,631,687
52-wk High
¥39.39
52-wk Low
¥18.90

Chart for

About

ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine... (more)

Overall

Beta: 0.63
Market Cap(Mil.): ¥36,445.46
Shares Outstanding(Mil.): 1,042.49
Dividend: 0.20
Yield (%): 0.57

Financials

  600521.SS Industry Sector
P/E (TTM): 55.22 28.57 32.53
EPS (TTM): 0.63 -- --
ROI: 12.49 13.08 12.63
ROE: 13.80 14.80 14.50

BRIEF-Zhejiang Huahai Pharmaceutical's Preliminary 2017 Net Profit Up 26.45 Pct Y/Y

* SAYS PRELIM 2017 NET PROFIT UP 26.45 PERCENT Y/Y AT 633.29 MILLION YUAN ($101.16 million) Source text in Chinese: http://bit.ly/2Bf04WM Further company coverage: ($1 = 6.2600 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Feb 07 2018

BRIEF-Zhejiang Huahai Pharmaceutical says fire accident in unit's warehouse

* Says fire accident has occurred at a warehouse of co's Zhejiang-based wholly owned pharmaceutical unit, on Jan. 18

Jan 19 2018

Earnings vs. Estimates